Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is valproate monotherapy a practical possibility in chronically uncontrolled epilepsy?

D J Armour1, G B Veitch

  • 1St Lawrence's Hospital, Caterham, U.K.

Journal of Clinical Pharmacy and Therapeutics
|February 1, 1988
PubMed
Summary

Valproate monotherapy was ineffective for institutionalized epilepsy patients, worsening seizure control. Carbamazepine, with or without valproate, offered improved seizure management and allowed phasing out of problematic drugs like phenobarbitone and phenytoin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Paper on THE DIAGNOSIS AND TREATMENT OF SPINAL CORD TUMOURS.

British medical journal·2010
Same author

Transfer of anthracnose resistance and pod coiling traits from Medicago arborea to M. sativa by sexual reproduction.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2008
Same author

Identification of QTL for resistance and susceptibility to Stagonospora meliloti in autotetraploid lucerne.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2007
Same author

Identification of QTL for reaction to three races of Colletotrichum trifolii and further analysis of inheritance of resistance in autotetraploid lucerne.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2007
Same author

Differences in drug prescribing patterns in elderly parkinsonian patients identified at hospital admission.

Pharmacy world & science : PWS·1998
Same author

The economics of a pharmacy-based central intravenous additive service for paediatric patients.

PharmacoEconomics·1996

Area of Science:

  • Neurology
  • Clinical Pharmacology
  • Epileptology

Background:

  • Epilepsy management in institutionalized individuals with intellectual disabilities often involves polytherapy.
  • Optimizing antiepileptic drug regimens is crucial for improving seizure control and minimizing adverse effects.

Purpose of the Study:

  • To evaluate the efficacy and safety of transitioning from polytherapy to valproate monotherapy in institutionalized male epileptic patients.
  • To assess the impact of carbamazepine addition or substitution on seizure control.
  • To investigate the relationship between valproate serum levels and clinical outcomes.

Main Methods:

  • Prospective open study involving 20 male residents of a mental handicap institution with epilepsy.
  • Gradual reduction of polytherapy to valproate monotherapy in 18 subjects.

Related Experiment Videos

  • Addition or substitution with carbamazepine for subjects with inadequate seizure control.
  • Monitoring of seizure frequency, adverse effects, and serum drug levels.

    • Main Results:

    • Valproate monotherapy was associated with a significant disadvantage in seizure frequency control.
    • Addition or substitution with carbamazepine led to significant improvements in seizure control.
    • Phenobarbitone and phenytoin were successfully phased out.
    • No clear association was found between valproate serum levels and seizure control or toxicity, despite some instances of pancreatitis and thrombocytopenia.
    • No tremor or weight gain was observed with valproate.

    Conclusions:

    • Valproate monotherapy is not appropriate for institutionalized patients with chronically uncontrolled seizures.
    • Carbamazepine, alone or in combination with valproate, represents a more effective treatment strategy for this population.
    • Discontinuation of phenobarbitone and phenytoin was achieved without apparent negative consequences.